Market Overview

UPDATE: Canaccord Genuity Downgrades USANA Health Sciences to Hold on Management Transition

Share:
Related USNA
This Was A 'Profound Victory' For Herbalife
Earnings Scheduled For May 3, 2016
USANA Health Sciences' (USNA) CEO Dave Wentz on Q2 2016 Results - Earnings Call Transcript (Seeking Alpha)

Canaccord Genuity reduced its rating on USANA Health Sciences (NYSE: USNA) from Buy to Hold and lowered its price target from $60 to $40.

Canaccord Genuity commented, "While the beginnings of improvement in US sales trends and a modest valuation had attracted us to USNA shares, we expect that another management transition is likely to inhibit a normalization of the valuation. … While USNA's valuation is modest, and even discounted relative to its peers, we expect added organizational risk will lead to a perpetuated valuation discount and the shares could lag its peers in any normalization of the sector valuations."

USANA Health Sciences closed at $38.42 on Thursday.

Latest Ratings for USNA

DateFirmActionFromTo
Feb 2016DA DavidsonDowngradesBuyNeutral
Sep 2015DA DavidsonUpgradesNeutralBuy
Aug 2015DA DavidsonDowngradesBuyNeutral

View More Analyst Ratings for USNA
View the Latest Analyst Ratings

Posted-In: Canaccord GenuityAnalyst Color Downgrades Pre-Market Outlook Analyst Ratings

 

Related Articles (USNA)

View Comments and Join the Discussion!